The solid tumor cancer treatment market is set to reach from US$ 121.3 Bn in 2018 to US$ 424.6 Bn by 2027 at a compound annual growth rate (CAGR) of 15.0% during the forecast period from 2019 to 2027. According to the latest statistics presented by the World Health Organization (WHO) in 2018, approximately 9.6 million people are estimated to die due to cancer; they also claim that 30 to 50% of cancer can be prevented with early diagnosis and effective treatment regimen.

The global breast prosthesis market expected to grow at compound annual growth rate (CAGR) of 9.3% during the forecast period from 2018 to 2026. The market is projected to grow during the forecast period owing to rising prevalence of breast cancer and mastectomy related to breast cancer. According to Cancer Research UK, more than 55,000 new cases of breast cancer is diagnosed every year in the United Kingdom.

Polymyositis treatment market projected to grow at a CAGR of 5.9% during the forecast period from 2019 to 2027. Polymyositis is rare connective tissue disease that causes muscle inflammation leading to muscle weakness. According to prevalence studies, globally the incidence of polymyositis is around 1 to 5 per 100,000 individuals and the prevalence is approximately 5 to 22 per 100,000 individuals. Thus, high awareness related to polymyositis diagnosis & treatment, strong drug pipeline, and rising geriatric population expected to assist the growth of polymyositis treatment market in the near future.

This report on global osteoarthritis treatment market studies various type of therapeutics used for treatment of osteoarthritis along with pipeline analysis of upcoming potential drugs. Globally, osteoarthritis is the eighth leading cause of disability with the joint most frequently associated with disability being the knee. The current treatment available for osteoarthritis treatment is incapable due to lack of efficacy and serious side-effects associated with the long term use.

Paget’s disease treatment market is projected to grow at a CAGR of 3.4% during the forecast period from 2019 to 2027. Paget’s disease of bone affects the way that bone is renewed & repaired, during this process an uncontrolled level of bone generation occurs that results into an abnormal bone formation. The affected bone is weaker than normal and leads to a bend or deformity making that bone fragile. According to Arthritis Research UK, Paget’s disease is identified as the most common disease in UK and also observed in people from Southern & Western Europe including other countries such as Australia & New Zealand.

Topical oxygen therapy market expected to reach by US$ 280.1 Mn by 2026 with CAGR of 3.5% during the forecast period from 2018 to 2026. Factors driving this market include growing incidence of chronic wounds, increasing patient pool of diabetics, and high incidence of wound site infections. Some of the major trends responsible for market growth are increased number of surgical procedures, and technological advancement in advanced wound care. Additionally, evolution of advanced wound management products, introduction of products at subsidized prices and greater number of initiatives undertaken by governments and healthcare organizations will open new opportunities for topical oxygen therapy market during the forecast period from 2018 to 2026.

Actinic keratosis (AK) or solar keratosis are keratotic papules, macules and plaques arising from intraepidermal proliferation of keratinocytes due to exposure to ultraviolet radiation. Although AKs to squamous cell carcinoma progression is rare, AKs still pose a concern because majority of cutaneous squamous cell carcinoma result from pre-existing AKs. Due to this, clinicians recommend routine treatment of AKs. This report studies the current and future prospects of the global actinic keratosis treatment market.

According to National Organization of Rare Disorders (NORD), acquired hemophilia is a rare autoimmune disorder characterized by bleeding that occurs in patients with a personal and family history negative for hemorrhages. In acquired hemophilia, the body produces antibodies that attack clotting factors, most often factor VIII. Medical practitioners suggest that, acquired hemophilia can potentially cause life-threatening bleeding complications in severe cases and in around 50% of cases, there is an identifiable underlying clinical condition; in the other 50% no cause is known i.e. idiopathic

The growing inclination of customers towards less-noisy products has influenced the global noise control system market. Noise pollution is one of the cause of stress increment in the work as well as residential locations. It has not only reduces the working efficiency of the employees but also putting them into stressful conditions.

Neutropenia treatment accounted for a market value of US$ 11,279.2 Mn in 2018 and projected to grow at a CAGR of 5.0% during the forecast period from 2019 to 2027. In neutropenia count of neutrophil falls giving rise to compromised immunity further increasing the risk of infection. Neutropenia is observed in almost half cases of cancer patients being treated with chemotherapy but out of them most are suffering from leukaemia. According to medical experts, neutropenia can be a chronic condition because without adequate neutrophils patient become vulnerable to life threatening infections.

The neurotrophic keratitis market is set to highlight rapid growth at a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2019 to 2027. Neurotrophic keratitis is an orphan disease which is primarily caused due to the damage of the fifth cranial nerve from the trigeminal nucleus to the nerve endings preset in the eye corneal region. Traditional therapies are employed to suppress the clinical manifestation occurring in different stages of the disease.

Globally, the nanobots market is expected to grow with a CAGR of more than 25% during the forecast period from 2019 to 2027, starting from US$80 Bn in 2018. Globally, rapid technological advancements resulted into development of robots and nanorobots/nanobots. The growing field of nanotechnology has emerged as a driving force for usage of nanobots. Nanobots are developed to be used in various fields for different applications to be performed thus reducing human errors. Additionally, factors such as increasing government funding in advancement of nanorobotics, rising focus on regenerative medicine and nanotechnology, and rapid expansions in molecular robots.

Globally, the medical recruitment market is expected to grow with a CAGR of 4.5% during the forecast period from 2019 to 2027. The increasing shortage of the healthcare professionals across the healthcare industry is augmenting the demand for the medical recruitment services. The growing demand for the healthcare services across the globe due to increasing prevalence of the chronic diseases is giving rise to the requirement of the healthcare professionals.

The learning disability treatment market is set to reach US$ 30,493.1 Mn by 2027 from US$ 17,418.0 Mn in 2018 highlighting steady growth at a compounded annual growth rate (CAGR) of 6.5% during the forecast period from 2019 to 2027. Children with learning disability have tremendous mental ability but due to irregular impulses generated by the central nervous system they suffer with altered behavior and lower cognitive skills.

The hypoactive sexual desire disorder treatment market is set to expand at a compounded annual growth rate (CAGR) of 5.2% during the forecast period from 2019 to 2027. Hypoactive sexual desire disorder (HSDD) can be primary, secondary, lifelong or situational; currently physicians worldwide are employing either psychotherapy or pharmacotherapy for its treatment. Recent approval of Bremelanotide (Vyleesi) will propel the HSDD market growth in the near future. Currently 2 drugs such as Prasterone 6.5 mg vaginal insert and BP101 are under phase 3 clinical trial being investigated for its safety and efficacy for treating HSDD.

The global freezing of gait treatment market is growing effectually, expected to grow at a CAGR of 7.2%. Globally, increasing prevalence of Parkinson's disease has significantly increased the revenue of oral dopaminergic medications. FDA approval for new drugs, and promising pipeline products in the equipment and devices segment in the Parkinson's disease industry are driving the overall growth freezing of gait treatment market globally.

Dravet syndrome treatment accounted for a market value of US$ 209.2 Mn in 2018 and projected to grow at a CAGR of 11.7% during the forecast period from 2019 to 2027. The current treatment options available for Dravet syndrome target specifically the symptomatic relief associated with epileptic seizures. However, recent drug approvals for Dravet syndrome treatment has increased the overall market size and attracted attention of major pharmaceutical companies.

The donor egg IVF treatment market is set to reach US$ 3,676.8 Mn by 2027 from US$ 1,782.1 Mn in 2018 highlighting moderate growth at a compounded annual growth rate (CAGR) of 8.4% during the forecast period from 2019 to 2027. In the last 2 decades there has been a paradigm shift observed in the society which has major influence over the consistently growing infertility rate. Significant rise in working women, delayed marriages, advanced maternal age etc provide a positive impetus for the donor egg IVF treatment market.

Devic’s syndrome (Neuromyelitis optica) treatment accounted for a market value of US$ 156.8 Mn in 2018 and projected to grow at a CAGR of 12.0% during the forecast period from 2019 to 2027. Devic's disease or neuromyelitis optica is an autoimmune disease in which antibodies and immune system cells mainly damage the optic nerves and the spinal cord, but in a few cases affect the brain. The injury to optical nerves leads to inflammation and soreness leading to vision loss and pain; the injury to the spinal cord leads to paralysis in the arms or legs, loss of sensation, and problems with bladder & bowel function.

The global dermal fillers market is growing efficiently, expected to grow at a CAGR of 6.6%. Globally, growing minimally invasive cosmetic procedures has significantly increased the revenue of dermal fillers. Innovative application launches along with raised demand for medical aesthetics, and promising pipeline products in the aesthetics industry are factors driving the overall growth of dermal fillers market globally. Increasing commonness of imbalance diet, stress and insomnia among individuals will further spur revenue growth during the forecast period.